On February 24, 2023, the Drug Enforcement Administration (DEA) released its proposed rules for telemedicine and controlled medications. Lucky for you, you’re with the first in the industry to chart a path through the requirements so that you can remain compliant and receive uninterrupted care.
In this form, your practitioner will request that ADHD Online continue to provide uninterrupted care
You or your practitioner can return this form to us via email
or fax it to 616-210-3118
Or your doctor can also provide a referral directly to us
Ask them to be sure to include their NPI and DEA number
Need more answers to your questions about ADHD, Assessment, Treatment, medication, and more? We’ve got you.
Rest assured that we are working hard to ensure that you will continue to receive care and treatment for your ADHD. As more information becomes available, we will continue to update you and keep you informed.
Submit a request
Phone: 888-493-ADHD (2343)
Monday – Friday
9:00 AM – 5:00 PM EST
© 2024 Mentavi Health, Inc. All Rights Reserved. | Privacy policy | Notice of privacy practices | Terms & conditions | No Show & Refund policy
If you are having suicidal thoughts please immediately call or text the National Suicide Prevention Hotline at 988
Mentavi Health is conducting ADHD research and is accepting a limited number of participants. Participants in our clinical study will get an ADHD Assessment at no cost.
In this form, your practitioner will request that ADHD Online continue to provide uninterrupted care
